Testing methods are optimized for the true chemical composition of formulated matrices.
Hou Y, Dan X, Babbar M, Wei Y, Hasselbalch SG, Croteau DL, Bohr VA (2019) Ageing as a risk factor for neurodegenerative disease
2 PubMed (BPC-157 angiogenesis)BPC-157 and angiogenic / cytoprotective effects reported in rodent injury models
Exfoliating acids and low-pH ingredients, such as vitamin C, may be incompatible with GHK-Cu, Dr
Key gaps include: No large-scale randomised controlled trials in humans the evidence basis for clinical use is extrapolated from animal data and small pilot studies No long-term safety data effects beyond 1216 weeks are not well characterised Variable results in human sleep trials some early human studies showed modest or inconsistent effects on sleep architecture compared to animal data, suggesting the translation may not be linear No FDA approval DSIP is not approved for any therapeutic use in the United States Stability concerns DSIP degrades relatively quickly in circulation
